GlassScriptPhysician profile
Greg S Orlando
NPI 1265456412
$3,546.27
in general payments reported to CMS, 2019-2025
27 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $396 · 2021: $576 · 2022: $190 · 2023: $700 · 2024: $478 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $990 · Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.85 |
| Food and Beverage | $986.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,029.19 | 2019-2024 | |
| Smith+Nephew, INC. | $569.79 | 2019-2023 | Endobutton |
| Arthrex, INC. | $487.45 | 2025 | |
| Endo USA, INC. | $187.85 | 2025 | Xiaflex |
| Medacta USA, INC. | $183.22 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $176.34 | 2019-2024 | Xiaflex |
| Horizon Therapeutics Plc | $122.78 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $119.08 | 2019-2021 | |
| Lifenet Health | $119.06 | 2024 | Allograft Vmis Delivery System |
| Depuy Synthes Sales INC. | $106.64 | 2019 | |
| Medela LLC | $61.39 | 2022 | |
| Molnlycke Health Care US, LLC | $44.01 | 2020 | |
| Tela Bio, INC. | $42.27 | 2019-2021 | |
| Tactile Systems Technology INC | $39.52 | 2025 | Flexitouch Plus, Nimbl |
| Vertex Pharmaceuticals Incorporated | $34.72 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $34.48 | 2023 | Dynasplint |
| Acera Surgical, INC. | $28.22 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $21.43 | 2025 | Juggerstitch, Juggerloc |
| Solventum Corporation | $19.66 | 2024 | Activ.A.C. |
| Next Science LLC | $19.61 | 2022 | |
| Aesculap, INC. | $19.00 | 2024 | Elan 4 |
| Spr Therapeutics, INC | $17.26 | 2025 | Sprint Pns System |
| Csl Behring | $17.13 | 2019 | |
| Springworks Therapeutics, INC. | $15.99 | 2025 | Ogsiveo |
| Convatec INC. | $15.12 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Orlando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.